CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project seeks to develop a new therapy for colorectal cancer by targeting a specific long non-coding RNA involved in drug resistance. The approach aims to enhance treatment efficacy by combining RNA inhibitors with traditional therapies to overcome resistance mechanisms.
Colorectal cancer (CRC) is the third leading cause of cancer-related death globally.
Despite the therapeutic advances, innate and acquired resistance is still an adversity that needs to be overcome.
Therefore, there is an urgent need to identify more targeted and specific therapeutic approaches in order to increase success of the treatment and reduce the medical and economic burden of therapeutic failures.
Numerous studies have been conducted to target the replication stress response, a hallmark…
FUNDACION PARA LA INVESTIGACION MEDICA APLICADA FIMA
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Italy, ROMA RM
Type: SME
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: Yes
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
